{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:29:20Z","timestamp":1793863760282,"version":"4.6.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100020203","name":"Guizhou Provincial Health and Family Planning Commission","doi-asserted-by":"publisher","award":["gzwk j2021-176"],"award-info":[{"award-number":["gzwk j2021-176"]}],"id":[{"id":"10.13039\/501100020203","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10528-023-10616-1","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T05:02:11Z","timestamp":1704862931000},"page":"3681-3694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["BCLAF1 is Expressed as a Potential Anti-oncogene in Bile Duct Cancer"],"prefix":"10.1007","volume":"62","author":[{"given":"Yutong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,10]]},"reference":[{"key":"10616_CR1","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1096\/fj.201701073R","volume":"32","author":"H Bao","year":"2018","unstructured":"Bao H, Chen YX, Huang K, Zhuang F, Bao M, Han Y, Chen XH, Shi Q, Yao QP, Qi YX (2018) Platelet-derived microparticles promote endothelial cell proliferation in hypertension via miR-142-3p. Faseb j 32:3912\u20133923","journal-title":"Faseb j"},{"key":"10616_CR2","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/leu.2017.64","volume":"31","author":"CC Dell\u2019Aversana","year":"2017","unstructured":"Dell\u2019Aversana CC, Giorgio C, D\u2019Amato L, Lania G, Matarese F, Saeed S, Di Costanzo A, Belsito Petrizzi V, Ingenito C, Martens JHA, Pallavicini I, Minucci S, Carissimo A, Stunnenberg HG, Altucci L (2017) miR-194-5p\/BCLAF1 deregulation in AML tumorigenesis. Leukemia 31:2315\u20132325","journal-title":"Leukemia"},{"key":"10616_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","volume":"5","author":"MZ Jin","year":"2020","unstructured":"Jin MZ, Jin WL (2020) The updated landscape of tumor microenvironment and drug repurposing. Signal Transduct Target Ther 5:166","journal-title":"Signal Transduct Target Ther"},{"key":"10616_CR4","doi-asserted-by":"publisher","first-page":"771","DOI":"10.21873\/invivo.11307","volume":"32","author":"IH Jung","year":"2018","unstructured":"Jung IH, Kim DH, Yoo DK, Baek SY, Jeong SH, Jung DE, Park SW, Chung YY (2018) In vivo study of natural killer (NK) cell cytotoxicity against cholangiocarcinoma in a nude mouse model. In Vivo 32:771\u2013781","journal-title":"In Vivo"},{"key":"10616_CR5","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.7314\/APJCP.2016.17.4.2205","volume":"17","author":"SJ Kaewpitoon","year":"2016","unstructured":"Kaewpitoon SJ, Rujirakul R, Loyd RA, Panpimanmas S, Matrakool L, Tongtawee T, Kompor P, Norkaew J, Chavengkun W, Wakkhuwattapong P, Kujapun J, Ponphimai S, Phatisena T, Eaksunti T, Polsripradist P, Joosiri A, Sukkasam I, Padchasuwan N, Kaewpitoon N (2016) Surveillance of populations at risk of cholangiocarcinoma development in rural communities of thailand using the Korat-CCA verbal screening test. Asian Pac J Cancer Prev 17:2205\u20132209","journal-title":"Asian Pac J Cancer Prev"},{"key":"10616_CR6","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/hep.29904","volume":"68","author":"Y Kurebayashi","year":"2018","unstructured":"Kurebayashi Y, Ojima H, Tsujikawa H, Kubota N, Maehara J, Abe Y, Kitago M, Shinoda M, Kitagawa Y, Sakamoto M (2018) Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification. Hepatology 68:1025\u20131041","journal-title":"Hepatology"},{"key":"10616_CR7","doi-asserted-by":"publisher","first-page":"e359","DOI":"10.1038\/cddis.2012.76","volume":"3","author":"YY Lee","year":"2012","unstructured":"Lee YY, Yu YB, Gunawardena HP, Xie L, Chen X (2012) BCLAF1 is a radiation-induced H2AX-interacting partner involved in \u03b3H2AX-mediated regulation of apoptosis and DNA repair. Cell Death Dis 3:e359","journal-title":"Cell Death Dis"},{"key":"10616_CR8","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS (2017) TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res 77:e108\u2013e110","journal-title":"Cancer Res"},{"key":"10616_CR9","doi-asserted-by":"publisher","first-page":"8480","DOI":"10.1128\/MCB.01126-07","volume":"27","author":"H Liu","year":"2007","unstructured":"Liu H, Lu ZG, Miki Y, Yoshida K (2007) Protein kinase C delta induces transcription of the TP53 tumor suppressor gene by controlling death-promoting factor Btf in the apoptotic response to DNA damage. Mol Cell Biol 27:8480\u20138491","journal-title":"Mol Cell Biol"},{"key":"10616_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/cdd.2008.167","volume":"16","author":"JP Mcpherson","year":"2009","unstructured":"Mcpherson JP, Sarras H, Lemmers B, Tamblyn L, Migon E, Matysiak-Zablocki E, Hakem A, Azami SA, Cardoso R, Fish J, Sanchez O, Post M, Hakem R (2009) Essential role for Bclaf1 in lung development and immune system function. Cell Death Differ 16:331\u2013339","journal-title":"Cell Death Differ"},{"key":"10616_CR11","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.1021\/pr9005316","volume":"8","author":"AF R\u00e9nert","year":"2009","unstructured":"R\u00e9nert AF, Leprince P, Dieu M, Renaut J, Raes M, Bours V, Chapelle JP, Piette J, Merville MP, Fillet M (2009) The proapoptotic C16-ceramide-dependent pathway requires the death-promoting factor Btf in colon adenocarcinoma cells. J Proteome Res 8:4810\u20134822. https:\/\/doi.org\/10.1021\/pr9005316","journal-title":"J Proteome Res"},{"key":"10616_CR12","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1100\/tsw.2010.132","volume":"10","author":"H Sarras","year":"2010","unstructured":"Sarras H, Alizadeh Azami S, Mcpherson JP (2010) In search of a function for BCLAF1. ScientificWorldJournal 10:1450\u20131461","journal-title":"ScientificWorldJournal"},{"key":"10616_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.molcel.2014.03.021","volume":"54","author":"KI Savage","year":"2014","unstructured":"Savage KI, Gorski JJ, Barros EM, Irwin GW, Manti L, Powell AJ, Pellagatti A, Lukashchuk N, Mccance DJ, Mccluggage WG, Schettino G, Salto-Tellez M, Boultwood J, Richard DJ, Mcdade SS, Harkin DP (2014) Identification of a BRCA1-mRNA splicing complex required for efficient DNA repair and maintenance of genomic stability. Mol Cell 54:445\u2013459","journal-title":"Mol Cell"},{"key":"10616_CR14","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/cdd.2015.150","volume":"23","author":"AW Shao","year":"2016","unstructured":"Shao AW, Sun H, Geng Y, Peng Q, Wang P, Chen J et al (2016) Bclaf1 is an important NF-\u03baB signaling transducer and C\/EBP \u03b2 regulator in DNA damage-induced senescence. Cell Death Differ 23:865","journal-title":"Cell Death Differ"},{"key":"10616_CR15","first-page":"2807","volume":"39","author":"A Shao","year":"2020","unstructured":"Shao A, Lang Y, Wang M, Qin C, Kuang Y, Mei Y, Lin D, Zhang S, Tang J (2020) Bclaf1 is a direct target of HIF-1 and critically regulates the stability of HIF-1\u03b1 under hypoxia. Antioncogene 39:2807\u20132818","journal-title":"Antioncogene"},{"key":"10616_CR16","doi-asserted-by":"publisher","first-page":"7371","DOI":"10.1007\/s13277-015-4410-2","volume":"37","author":"B Shen","year":"2016","unstructured":"Shen B, Tan M, Mu X, Qin Y, Zhang F, Liu Y, Fan Y (2016) Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagy. Tumour Biol 37:7371\u20137381","journal-title":"Tumour Biol"},{"issue":"4","key":"10616_CR17","first-page":"577","volume":"15","author":"S Sribenja","year":"2016","unstructured":"Sribenja S, Natthasirikul N, Vaeteewoottacharn K, Sawanyawisuth K, Wongkham C, Jearanaikoon P, Wongkham, Thymosin S (2016) \u03b210 as a predictive biomarker of response to 5-fluorouracil chemotherapy in cholangiocarcinoma. Ann Hepatol 15(4):577\u2013585","journal-title":"Ann Hepatol"},{"key":"10616_CR18","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4161\/nucl.25187","volume":"4","author":"S Varia","year":"2013","unstructured":"Varia S, Potabathula D, Deng Z, Bubulya A, Bubulya PA (2013) Btf and TRAP150 have distinct roles in regulating subcellular mRNA distribution. Nucleus 4:229\u2013240","journal-title":"Nucleus"},{"key":"10616_CR19","doi-asserted-by":"publisher","first-page":"12816","DOI":"10.1093\/nar\/gkx1046","volume":"45","author":"J Vohhodina","year":"2017","unstructured":"Vohhodina J, Barros EM, Savage AL, Liberante FG, Manti L, Bankhead P, Cosgrove N, Madden AF, Harkin DP, Savage KI (2017) The RNA processing factors THRAP3 and BCLAF1 promote the DNA damage response through selective mRNA splicing and nuclear export. Nucleic Acids Res 45:12816\u201312833","journal-title":"Nucleic Acids Res"},{"key":"10616_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.2217\/bmm-2015-0062","volume":"10","author":"B Wang","year":"2016","unstructured":"Wang B, Chen L, Chang HT (2016) Potential diagnostic and prognostic biomarkers for cholangiocarcinoma in serum and bile. Biomark Med 10:613\u2013619","journal-title":"Biomark Med"},{"key":"10616_CR21","first-page":"1845","volume":"38","author":"Y Wen","year":"2019","unstructured":"Wen Y, Zhou X, Lu M, He M, Tian Y, Liu L, Wang M, Tan W, Deng Y, Yang X, Mayer MP, Zou F, Chen X (2019) Bclaf1 promotes angiogenesis by regulating HIF-1\u03b1 transcription in hepatocellular carcinoma. Antioncogene 38:1845\u20131859","journal-title":"Antioncogene"},{"key":"10616_CR22","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/hepr.13395","volume":"49","author":"S Yu","year":"2019","unstructured":"Yu S, Wang X, Dou N, Zhou J, Gao Y, Li Y (2019) B-cell lymphoma-2-associated transcription factor-1 is overexpressed and contributes to sorafenib resistance in hepatocellular carcinoma. Hepatol Res 49:1329\u20131340. https:\/\/doi.org\/10.1111\/hepr.13395","journal-title":"Hepatol Res"},{"issue":"2","key":"10616_CR23","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3892\/ol.2021.13176","volume":"23","author":"Z Yu","year":"2022","unstructured":"Yu Z, Zhu J, Wang H, Li H, Jin X (2022) Function of BCLAF1 in human disease. Oncol Lett 23(2):58. https:\/\/doi.org\/10.3892\/ol.2021.13176","journal-title":"Oncol Lett"},{"key":"10616_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12964-019-0332-8","volume":"17","author":"M Zhang","year":"2019","unstructured":"Zhang M, Pan Y, Tang D, Dorfman RG, Xu L, Zhou Q, Zhou L, Wang Y, Li Y, Yin Y, Kong B, Friess H, Zhao S, Wu JL, Wang L, Zou X (2019) Low levels of pyruvate induced by a positive feedback loop protects cholangiocarcinoma cells from apoptosis. Cell Commun Signal 17:23","journal-title":"Cell Commun Signal"},{"key":"10616_CR25","doi-asserted-by":"publisher","first-page":"583334","DOI":"10.3389\/fphar.2020.583334","volume":"11","author":"S Zhang","year":"2020","unstructured":"Zhang S, Zhang M, Chen J, Zhao J, Su J, Zhang X (2020) Ginsenoside compound K regulates HIF-1\u03b1-mediated glycolysis through bclaf1 to inhibit the proliferation of human liver cancer cells. Front Pharmacol 11:583334. https:\/\/doi.org\/10.3389\/fphar.2020.583334","journal-title":"Front Pharmacol"},{"key":"10616_CR26","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1038\/ncomms5581","volume":"5","author":"X Zhou","year":"2014","unstructured":"Zhou X, Li X, Cheng Y, Wu W, Xie Z, Xi Q, Han J, Wu G, Fang J, Feng Y (2014) BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells. Nat Commun 5:4581","journal-title":"Nat Commun"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-023-10616-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-023-10616-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-023-10616-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T16:28:12Z","timestamp":1727368092000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-023-10616-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,10]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10616"],"URL":"https:\/\/doi.org\/10.1007\/s10528-023-10616-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3277527\/v1","asserted-by":"object"}]},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,10]]},"assertion":[{"value":"19 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}